World's Best Scientists 2026 revealed!
Award Badge
Medicine
Poland
2026

D-Index & Metrics

Medicine

D-Index
101
Citations
110355
World Ranking
7770
National Ranking
10

Research.com Recognitions

  • 2026 - Research.com Medicine in Poland Leader Award
  • 2025 - Research.com Medicine in Poland Leader Award
  • 2023 - Research.com Medicine in Poland Leader Award
  • 2022 - Research.com Medicine in Poland Leader Award

Overview

Andrzej Budaj is affiliated with the Center of Postgraduate Medical Education at Grochowski Hospital in Poland. Their research primarily spans the field of Medicine with a strong focus on Cardiology and Cardiovascular Medicine, complemented by contributions to Surgery, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, and Radiology, Nuclear Medicine and Imaging.

The scientist's work covers several important topics including Acute Myocardial Infarction Research, Cardiovascular Function and Risk Factors, Antiplatelet Therapy and Cardiovascular Diseases, Lipoproteins and Cardiovascular Health, Cardiovascular Effects of Exercise, Atrial Fibrillation Management and Outcomes, and Coronary Interventions and Diagnostics.

They have published extensively in frequent venues such as the European Heart Journal, Circulation, Kardiologia Polska, European Heart Journal - Quality of Care and Clinical Outcomes, and the Journal of the American Heart Association.

Frequent coauthors collaborating with Andrzej Budaj include Aldo P. Maggioni, Beata Zaborska, Deepak L. Bhatt, Chris P Gale, and Philippe Gabríel Steg.

Some recent publications of Andrzej Budaj include:

  • 2024 ESC Guidelines for the management of chronic coronary syndromes, 2024, European Heart Journal
  • Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus, 2020, Circulation
  • Health-Related Quality of Life and Mortality in Heart Failure: The Global Congestive Heart Failure Study of 23 000 Patients From 40 Countries, 2021, Circulation
  • A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction, 2022, Circulation
  • Comparative Efficacy and Safety of Oral P2Y 12 Inhibitors in Acute Coronary Syndrome, 2020, Circulation

Best Publications

  • Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

    Salim Yusuf;Steven Hawken;Stephanie Ôunpuu;Tony Dans

  • ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society

    Valentin Fuster;Lars E. Rydén;David S. Cannom;Harry J. Crijns

  • Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

    Lars Wallentin;Richard C. Becker;Andrzej Budaj;Christopher P. Cannon

  • 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.

    Gilles Montalescot;Udo Sechtem;Stephan Achenbach;Felicita Andreotti

  • Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology

    Alec Vahanian;Helmut Baumgartner;Jeroen Bax;Eric Butchart

  • European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

    Guy De Backer;Ettore Ambrosioni;Knut Borch-Johnsen;Carlos Brotons

  • Apixaban in Patients with Atrial Fibrillation

    Stuart J. Connolly;John Eikelboom;Campbell Joyner;Hans-Christoph Diener

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

    Marco Valgimigli;Héctor Bueno;Robert A Byrne;Jean-Philippe Collet

  • Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

    Lars Rydén;Eberhard Standl;Małgorzata Bartnik;Greet Van den Berghe

  • Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial.

    Sanjit S Jolly;Salim Yusuf;John Cairns;Kari Niemelä

  • ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.

    R Collins;R Peto;M Flather;S Parish

  • Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

    Marc P. Bonaca;Deepak L. Bhatt;Marc Cohen;Philippe Gabriel Steg

  • A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry

    Kim A Eagle;Michael J Lim;Omar H Dabbous;Karen S Pieper

  • Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial

    Johannes F. E. Mann;Roland E Schmieder;Matthew McQueen;Leanne Dyal

  • Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.

    Markku S. Nieminen;Silvia G. Priori;Maria Angeles Alonso Garcia;Andrzej Budaj

  • ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)

    Valentin Fuster;Lars E. Rydén;David S. Cannom;Harry J. Crijns

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • Comparison of fondaparinux and enoxaparin in acute coronary syndromes.

    Salim Yusuf;Shamir R. Mehta;Susan Chrolavicius;Rizwan Afzal

  • ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

    Douglas P. Zipes;A. John Camm;Martin Borggrefe;Alfred E. Buxton

  • ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary

    Valentin Fuster;Lars E. Rydén;David S. Cannom;Harry J. Crijns

Frequent Co-Authors

Keith A.A. Fox
Keith A.A. Fox University of Edinburgh
Lars Wallentin
Lars Wallentin Uppsala University
Salim Yusuf
Salim Yusuf McMaster University
Jose Lopez-Sendon
Jose Lopez-Sendon Hospital Universitario La Paz
Shamir R. Mehta
Shamir R. Mehta McMaster University
Christopher B. Granger
Christopher B. Granger Duke University
Alvaro Avezum
Alvaro Avezum Population Health Research Institute
Philippe Gabriel Steg
Philippe Gabriel Steg Université Paris Cité
Joel M. Gore
Joel M. Gore University of Massachusetts Chan Medical School
Shaun G. Goodman
Shaun G. Goodman University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring career options related to medicine in the USA, online nursing degrees provide flexible and affordable pathways. Many students start with nursing programs that allow them to work while completing their education. For those seeking cost-effective options, the rn to bsn online programs are designed for registered nurses who want to advance their qualifications and open doors to new roles in healthcare.

Advancement in nursing can also be achieved through specialized graduate degrees. For example, the affordable online fnp programs are ideal for nurses aiming to become Family Nurse Practitioners, a role in high demand. Those considering the next academic step beyond a Bachelor’s can research the cheapest rn to bsn online options or pursue advanced leadership and research roles with the cheapest dnp programs.

These online pathways offer opportunities for career advancement and skill specialization—all while helping to manage costs and maintain work-life balance. They are especially appealing for those committed to a future in healthcare but seeking alternatives to traditional medical degrees.

Best Scientists Citing Andrzej Budaj

Trending Scientists

Recently Published Articles